nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—HTR2C—Sorafenib—kidney cancer	0.0438	0.0751	CbGbCtD
Perphenazine—CYP2D6—Temsirolimus—kidney cancer	0.0431	0.0739	CbGbCtD
Perphenazine—CYP3A4—Everolimus—kidney cancer	0.0406	0.0695	CbGbCtD
Perphenazine—CYP2C8—Pazopanib—kidney cancer	0.0355	0.0608	CbGbCtD
Perphenazine—CYP1A2—Pazopanib—kidney cancer	0.0275	0.0471	CbGbCtD
Perphenazine—CYP3A4—Temsirolimus—kidney cancer	0.0274	0.047	CbGbCtD
Perphenazine—CYP2B6—Sorafenib—kidney cancer	0.0272	0.0466	CbGbCtD
Perphenazine—CYP2C9—Capecitabine—kidney cancer	0.0258	0.0443	CbGbCtD
Perphenazine—CYP2C8—Erlotinib—kidney cancer	0.0253	0.0434	CbGbCtD
Perphenazine—CYP2C8—Paclitaxel—kidney cancer	0.0232	0.0397	CbGbCtD
Perphenazine—CYP2D6—Pazopanib—kidney cancer	0.0226	0.0388	CbGbCtD
Perphenazine—CYP2C8—Sorafenib—kidney cancer	0.0206	0.0353	CbGbCtD
Perphenazine—CYP1A2—Erlotinib—kidney cancer	0.0196	0.0336	CbGbCtD
Perphenazine—CYP2C19—Sorafenib—kidney cancer	0.0173	0.0296	CbGbCtD
Perphenazine—CYP2B6—Doxorubicin—kidney cancer	0.0165	0.0283	CbGbCtD
Perphenazine—CYP2C9—Paclitaxel—kidney cancer	0.0162	0.0277	CbGbCtD
Perphenazine—CYP2D6—Erlotinib—kidney cancer	0.0162	0.0277	CbGbCtD
Perphenazine—CYP1A2—Sorafenib—kidney cancer	0.0159	0.0273	CbGbCtD
Perphenazine—CYP3A4—Pazopanib—kidney cancer	0.0144	0.0247	CbGbCtD
Perphenazine—CYP2C9—Sorafenib—kidney cancer	0.0144	0.0246	CbGbCtD
Perphenazine—CYP2D6—Sorafenib—kidney cancer	0.0131	0.0225	CbGbCtD
Perphenazine—CYP2D6—Vinblastine—kidney cancer	0.013	0.0222	CbGbCtD
Perphenazine—CYP3A4—Erlotinib—kidney cancer	0.0103	0.0176	CbGbCtD
Perphenazine—CYP3A4—Paclitaxel—kidney cancer	0.0094	0.0161	CbGbCtD
Perphenazine—CYP3A4—Sorafenib—kidney cancer	0.00835	0.0143	CbGbCtD
Perphenazine—CYP3A4—Vinblastine—kidney cancer	0.00825	0.0141	CbGbCtD
Perphenazine—CYP3A4—Vincristine—kidney cancer	0.00811	0.0139	CbGbCtD
Perphenazine—CYP2D6—Doxorubicin—kidney cancer	0.00797	0.0137	CbGbCtD
Perphenazine—CYP3A4—Sunitinib—kidney cancer	0.00677	0.0116	CbGbCtD
Perphenazine—CYP3A4—Doxorubicin—kidney cancer	0.00507	0.00869	CbGbCtD
Perphenazine—CYP2C19—urine—kidney cancer	0.00384	0.0697	CbGeAlD
Perphenazine—CYP1A2—urine—kidney cancer	0.00314	0.057	CbGeAlD
Perphenazine—CYP2C9—urine—kidney cancer	0.00298	0.0541	CbGeAlD
Perphenazine—HTR2A—urine—kidney cancer	0.00245	0.0445	CbGeAlD
Perphenazine—CYP3A4—urine—kidney cancer	0.00227	0.0412	CbGeAlD
Perphenazine—CYP2D6—urine—kidney cancer	0.00223	0.0406	CbGeAlD
Perphenazine—AOX1—nephron tubule—kidney cancer	0.00154	0.028	CbGeAlD
Perphenazine—AOX1—renal system—kidney cancer	0.0014	0.0254	CbGeAlD
Perphenazine—CALM3—nephron tubule—kidney cancer	0.00139	0.0252	CbGeAlD
Perphenazine—AOX1—kidney—kidney cancer	0.00135	0.0246	CbGeAlD
Perphenazine—AOX1—cortex of kidney—kidney cancer	0.00132	0.0239	CbGeAlD
Perphenazine—AOX1—gonad—kidney cancer	0.00126	0.0228	CbGeAlD
Perphenazine—AOX1—cardiac atrium—kidney cancer	0.00125	0.0228	CbGeAlD
Perphenazine—CALM3—cortex of kidney—kidney cancer	0.00119	0.0215	CbGeAlD
Perphenazine—CALM3—cardiac atrium—kidney cancer	0.00113	0.0205	CbGeAlD
Perphenazine—CALM2—nephron tubule—kidney cancer	0.00109	0.0198	CbGeAlD
Perphenazine—CALM1—nephron tubule—kidney cancer	0.00108	0.0197	CbGeAlD
Perphenazine—HTR1A—renal system—kidney cancer	0.00101	0.0183	CbGeAlD
Perphenazine—CALM2—renal system—kidney cancer	0.00099	0.018	CbGeAlD
Perphenazine—CALM1—renal system—kidney cancer	0.000985	0.0179	CbGeAlD
Perphenazine—HTR7—renal system—kidney cancer	0.000963	0.0175	CbGeAlD
Perphenazine—CALM2—kidney—kidney cancer	0.000957	0.0174	CbGeAlD
Perphenazine—CALM1—kidney—kidney cancer	0.000953	0.0173	CbGeAlD
Perphenazine—CALM2—cortex of kidney—kidney cancer	0.000932	0.0169	CbGeAlD
Perphenazine—HTR7—kidney—kidney cancer	0.000931	0.0169	CbGeAlD
Perphenazine—CALM1—cortex of kidney—kidney cancer	0.000928	0.0168	CbGeAlD
Perphenazine—CALM2—gonad—kidney cancer	0.000888	0.0161	CbGeAlD
Perphenazine—CALM2—cardiac atrium—kidney cancer	0.000886	0.0161	CbGeAlD
Perphenazine—CALM1—gonad—kidney cancer	0.000884	0.016	CbGeAlD
Perphenazine—CALM1—cardiac atrium—kidney cancer	0.000882	0.016	CbGeAlD
Perphenazine—HTR7—gonad—kidney cancer	0.000863	0.0157	CbGeAlD
Perphenazine—CYP2C8—renal system—kidney cancer	0.00082	0.0149	CbGeAlD
Perphenazine—CYP2B6—nephron tubule—kidney cancer	0.00081	0.0147	CbGeAlD
Perphenazine—CYP2C8—kidney—kidney cancer	0.000793	0.0144	CbGeAlD
Perphenazine—CYP1A2—renal system—kidney cancer	0.000768	0.0139	CbGeAlD
Perphenazine—CYP2B6—renal system—kidney cancer	0.000736	0.0134	CbGeAlD
Perphenazine—CYP2B6—kidney—kidney cancer	0.000711	0.0129	CbGeAlD
Perphenazine—ADRA2A—cortex of kidney—kidney cancer	0.000665	0.0121	CbGeAlD
Perphenazine—CYP2B6—gonad—kidney cancer	0.00066	0.012	CbGeAlD
Perphenazine—ADRA2A—gonad—kidney cancer	0.000633	0.0115	CbGeAlD
Perphenazine—ADRA2A—cardiac atrium—kidney cancer	0.000632	0.0115	CbGeAlD
Perphenazine—HTR2A—renal system—kidney cancer	0.0006	0.0109	CbGeAlD
Perphenazine—HTR2A—kidney—kidney cancer	0.00058	0.0105	CbGeAlD
Perphenazine—CYP3A4—renal system—kidney cancer	0.000556	0.0101	CbGeAlD
Perphenazine—CYP2D6—renal system—kidney cancer	0.000547	0.00993	CbGeAlD
Perphenazine—HTR2A—gonad—kidney cancer	0.000538	0.00977	CbGeAlD
Perphenazine—CYP3A4—kidney—kidney cancer	0.000537	0.00975	CbGeAlD
Perphenazine—CYP2D6—kidney—kidney cancer	0.000529	0.0096	CbGeAlD
Perphenazine—Ethopropazine—BCHE—kidney cancer	0.000429	0.148	CrCbGaD
Perphenazine—Insomnia—Everolimus—kidney cancer	0.000361	0.0019	CcSEcCtD
Perphenazine—Clomipramine—GSTP1—kidney cancer	0.00036	0.125	CrCbGaD
Perphenazine—Photosensitivity reaction—Paclitaxel—kidney cancer	0.000359	0.00189	CcSEcCtD
Perphenazine—Pruritus—Pazopanib—kidney cancer	0.000357	0.00188	CcSEcCtD
Perphenazine—Cough—Sunitinib—kidney cancer	0.000356	0.00188	CcSEcCtD
Perphenazine—Dyspnoea—Everolimus—kidney cancer	0.000356	0.00187	CcSEcCtD
Perphenazine—Cardiac arrest—Capecitabine—kidney cancer	0.000355	0.00187	CcSEcCtD
Perphenazine—Urinary retention—Capecitabine—kidney cancer	0.000355	0.00187	CcSEcCtD
Perphenazine—Hyperglycaemia—Paclitaxel—kidney cancer	0.000355	0.00187	CcSEcCtD
Perphenazine—Somnolence—Everolimus—kidney cancer	0.000355	0.00187	CcSEcCtD
Perphenazine—Dizziness—Temsirolimus—kidney cancer	0.000355	0.00187	CcSEcCtD
Perphenazine—Convulsion—Sunitinib—kidney cancer	0.000354	0.00186	CcSEcCtD
Perphenazine—Dry mouth—Sorafenib—kidney cancer	0.000353	0.00186	CcSEcCtD
Perphenazine—Dyskinesia—Doxorubicin—kidney cancer	0.000353	0.00186	CcSEcCtD
Perphenazine—Hypertension—Sunitinib—kidney cancer	0.000352	0.00186	CcSEcCtD
Perphenazine—Ataxia—Capecitabine—kidney cancer	0.000351	0.00185	CcSEcCtD
Perphenazine—Triflupromazine—BCHE—kidney cancer	0.000351	0.122	CrCbGaD
Perphenazine—Dysarthria—Doxorubicin—kidney cancer	0.000351	0.00185	CcSEcCtD
Perphenazine—Insomnia—Erlotinib—kidney cancer	0.000348	0.00183	CcSEcCtD
Perphenazine—Decreased appetite—Vinblastine—kidney cancer	0.000348	0.00183	CcSEcCtD
Perphenazine—Decreased appetite—Everolimus—kidney cancer	0.000347	0.00183	CcSEcCtD
Perphenazine—Anaphylactic shock—Sorafenib—kidney cancer	0.000346	0.00182	CcSEcCtD
Perphenazine—Leukopenia—Dactinomycin—kidney cancer	0.000346	0.00182	CcSEcCtD
Perphenazine—Diarrhoea—Pazopanib—kidney cancer	0.000346	0.00182	CcSEcCtD
Perphenazine—Infection—Sorafenib—kidney cancer	0.000344	0.00181	CcSEcCtD
Perphenazine—Dyspnoea—Erlotinib—kidney cancer	0.000343	0.00181	CcSEcCtD
Perphenazine—Pain—Vinblastine—kidney cancer	0.000342	0.0018	CcSEcCtD
Perphenazine—Constipation—Vinblastine—kidney cancer	0.000342	0.0018	CcSEcCtD
Perphenazine—Orthostatic hypotension—Capecitabine—kidney cancer	0.000341	0.0018	CcSEcCtD
Perphenazine—Constipation—Everolimus—kidney cancer	0.000341	0.0018	CcSEcCtD
Perphenazine—Pain—Everolimus—kidney cancer	0.000341	0.0018	CcSEcCtD
Perphenazine—Shock—Sorafenib—kidney cancer	0.000341	0.00179	CcSEcCtD
Perphenazine—Dry mouth—Sunitinib—kidney cancer	0.00034	0.00179	CcSEcCtD
Perphenazine—Headache—Temsirolimus—kidney cancer	0.000336	0.00177	CcSEcCtD
Perphenazine—Decreased appetite—Erlotinib—kidney cancer	0.000335	0.00176	CcSEcCtD
Perphenazine—Dizziness—Pazopanib—kidney cancer	0.000334	0.00176	CcSEcCtD
Perphenazine—Hepatocellular injury—Doxorubicin—kidney cancer	0.000332	0.00175	CcSEcCtD
Perphenazine—Infection—Sunitinib—kidney cancer	0.000331	0.00174	CcSEcCtD
Perphenazine—Anorexia—Sorafenib—kidney cancer	0.00033	0.00174	CcSEcCtD
Perphenazine—Muscular weakness—Capecitabine—kidney cancer	0.00033	0.00174	CcSEcCtD
Perphenazine—Constipation—Erlotinib—kidney cancer	0.000329	0.00173	CcSEcCtD
Perphenazine—Pain—Erlotinib—kidney cancer	0.000329	0.00173	CcSEcCtD
Perphenazine—Dermatitis contact—Doxorubicin—kidney cancer	0.000328	0.00173	CcSEcCtD
Perphenazine—Abnormal dreams—Doxorubicin—kidney cancer	0.000328	0.00173	CcSEcCtD
Perphenazine—Shock—Sunitinib—kidney cancer	0.000328	0.00173	CcSEcCtD
Perphenazine—Erythema—Gemcitabine—kidney cancer	0.000328	0.00173	CcSEcCtD
Perphenazine—Asthma—Capecitabine—kidney cancer	0.000323	0.0017	CcSEcCtD
Perphenazine—Dysphagia—Capecitabine—kidney cancer	0.000323	0.0017	CcSEcCtD
Perphenazine—Salivary hypersecretion—Doxorubicin—kidney cancer	0.000322	0.0017	CcSEcCtD
Perphenazine—Bradycardia—Paclitaxel—kidney cancer	0.000321	0.00169	CcSEcCtD
Perphenazine—Anorexia—Sunitinib—kidney cancer	0.000318	0.00167	CcSEcCtD
Perphenazine—Agitation—Vincristine—kidney cancer	0.000317	0.00167	CcSEcCtD
Perphenazine—Headache—Pazopanib—kidney cancer	0.000317	0.00167	CcSEcCtD
Perphenazine—Body temperature increased—Everolimus—kidney cancer	0.000315	0.00166	CcSEcCtD
Perphenazine—Hypoaesthesia—Paclitaxel—kidney cancer	0.000313	0.00165	CcSEcCtD
Perphenazine—Infection—Dactinomycin—kidney cancer	0.000313	0.00165	CcSEcCtD
Perphenazine—Oedema peripheral—Paclitaxel—kidney cancer	0.00031	0.00164	CcSEcCtD
Perphenazine—Leukopenia—Vincristine—kidney cancer	0.000309	0.00163	CcSEcCtD
Perphenazine—Dyspnoea—Sorafenib—kidney cancer	0.000309	0.00163	CcSEcCtD
Perphenazine—Pancytopenia—Capecitabine—kidney cancer	0.000307	0.00162	CcSEcCtD
Perphenazine—Body temperature increased—Erlotinib—kidney cancer	0.000304	0.0016	CcSEcCtD
Perphenazine—Insomnia—Sunitinib—kidney cancer	0.000301	0.00159	CcSEcCtD
Perphenazine—Decreased appetite—Sorafenib—kidney cancer	0.000301	0.00159	CcSEcCtD
Perphenazine—Anorexia—Dactinomycin—kidney cancer	0.000301	0.00158	CcSEcCtD
Perphenazine—Convulsion—Vincristine—kidney cancer	0.000299	0.00158	CcSEcCtD
Perphenazine—Hypertension—Vincristine—kidney cancer	0.000298	0.00157	CcSEcCtD
Perphenazine—Dyspnoea—Sunitinib—kidney cancer	0.000297	0.00156	CcSEcCtD
Perphenazine—Constipation—Sorafenib—kidney cancer	0.000296	0.00156	CcSEcCtD
Perphenazine—Pain—Sorafenib—kidney cancer	0.000296	0.00156	CcSEcCtD
Perphenazine—Hypersensitivity—Vinblastine—kidney cancer	0.000295	0.00155	CcSEcCtD
Perphenazine—Photosensitivity reaction—Capecitabine—kidney cancer	0.000295	0.00155	CcSEcCtD
Perphenazine—Hypersensitivity—Everolimus—kidney cancer	0.000294	0.00155	CcSEcCtD
Perphenazine—Leukopenia—Gemcitabine—kidney cancer	0.000293	0.00154	CcSEcCtD
Perphenazine—Hyperglycaemia—Capecitabine—kidney cancer	0.000291	0.00154	CcSEcCtD
Perphenazine—Decreased appetite—Sunitinib—kidney cancer	0.00029	0.00153	CcSEcCtD
Perphenazine—Cough—Gemcitabine—kidney cancer	0.000286	0.00151	CcSEcCtD
Perphenazine—Pain—Sunitinib—kidney cancer	0.000285	0.0015	CcSEcCtD
Perphenazine—Constipation—Sunitinib—kidney cancer	0.000285	0.0015	CcSEcCtD
Perphenazine—Hypertension—Gemcitabine—kidney cancer	0.000283	0.00149	CcSEcCtD
Perphenazine—Pruritus—Everolimus—kidney cancer	0.000282	0.00149	CcSEcCtD
Perphenazine—Anaphylactic shock—Vincristine—kidney cancer	0.000282	0.00148	CcSEcCtD
Perphenazine—Jaundice—Capecitabine—kidney cancer	0.000281	0.00148	CcSEcCtD
Perphenazine—Infection—Vincristine—kidney cancer	0.00028	0.00148	CcSEcCtD
Perphenazine—Urticaria—Sorafenib—kidney cancer	0.000275	0.00145	CcSEcCtD
Perphenazine—Photosensitivity—Doxorubicin—kidney cancer	0.000274	0.00145	CcSEcCtD
Perphenazine—Erythema—Paclitaxel—kidney cancer	0.000274	0.00144	CcSEcCtD
Perphenazine—Decreased appetite—Dactinomycin—kidney cancer	0.000274	0.00144	CcSEcCtD
Perphenazine—Diarrhoea—Vinblastine—kidney cancer	0.000274	0.00144	CcSEcCtD
Perphenazine—Body temperature increased—Sorafenib—kidney cancer	0.000274	0.00144	CcSEcCtD
Perphenazine—Diarrhoea—Everolimus—kidney cancer	0.000273	0.00144	CcSEcCtD
Perphenazine—Pruritus—Erlotinib—kidney cancer	0.000272	0.00143	CcSEcCtD
Perphenazine—Pain—Dactinomycin—kidney cancer	0.00027	0.00142	CcSEcCtD
Perphenazine—Agranulocytosis—Capecitabine—kidney cancer	0.000269	0.00142	CcSEcCtD
Perphenazine—Anorexia—Vincristine—kidney cancer	0.000269	0.00142	CcSEcCtD
Perphenazine—Eczema—Doxorubicin—kidney cancer	0.000268	0.00141	CcSEcCtD
Perphenazine—Anaphylactic shock—Gemcitabine—kidney cancer	0.000267	0.00141	CcSEcCtD
Perphenazine—Infection—Gemcitabine—kidney cancer	0.000266	0.0014	CcSEcCtD
Perphenazine—Dizziness—Vinblastine—kidney cancer	0.000265	0.0014	CcSEcCtD
Perphenazine—Dizziness—Everolimus—kidney cancer	0.000264	0.00139	CcSEcCtD
Perphenazine—Muscle spasms—Paclitaxel—kidney cancer	0.000264	0.00139	CcSEcCtD
Perphenazine—Body temperature increased—Sunitinib—kidney cancer	0.000263	0.00139	CcSEcCtD
Perphenazine—Diarrhoea—Erlotinib—kidney cancer	0.000263	0.00139	CcSEcCtD
Perphenazine—Hypotension—Vincristine—kidney cancer	0.000263	0.00139	CcSEcCtD
Perphenazine—Bradycardia—Capecitabine—kidney cancer	0.000263	0.00139	CcSEcCtD
Perphenazine—Vision blurred—Paclitaxel—kidney cancer	0.000258	0.00136	CcSEcCtD
Perphenazine—Hypoaesthesia—Capecitabine—kidney cancer	0.000257	0.00136	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.000255	0.00135	CcSEcCtD
Perphenazine—Hypersensitivity—Sorafenib—kidney cancer	0.000255	0.00134	CcSEcCtD
Perphenazine—Insomnia—Vincristine—kidney cancer	0.000255	0.00134	CcSEcCtD
Perphenazine—Anorexia—Gemcitabine—kidney cancer	0.000255	0.00134	CcSEcCtD
Perphenazine—Oedema peripheral—Capecitabine—kidney cancer	0.000255	0.00134	CcSEcCtD
Perphenazine—Dizziness—Erlotinib—kidney cancer	0.000255	0.00134	CcSEcCtD
Perphenazine—Flupentixol—ABCB1—kidney cancer	0.000253	0.0874	CrCbGaD
Perphenazine—Agitation—Paclitaxel—kidney cancer	0.000252	0.00133	CcSEcCtD
Perphenazine—Headache—Vinblastine—kidney cancer	0.000251	0.00132	CcSEcCtD
Perphenazine—Angioedema—Paclitaxel—kidney cancer	0.000251	0.00132	CcSEcCtD
Perphenazine—Headache—Everolimus—kidney cancer	0.00025	0.00132	CcSEcCtD
Perphenazine—Hypotension—Gemcitabine—kidney cancer	0.00025	0.00132	CcSEcCtD
Perphenazine—Body temperature increased—Dactinomycin—kidney cancer	0.000249	0.00131	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000249	0.00131	CcSEcCtD
Perphenazine—Hypoglycaemia—Doxorubicin—kidney cancer	0.000247	0.0013	CcSEcCtD
Perphenazine—Syncope—Paclitaxel—kidney cancer	0.000246	0.0013	CcSEcCtD
Perphenazine—Lethargy—Doxorubicin—kidney cancer	0.000246	0.0013	CcSEcCtD
Perphenazine—Leukopenia—Paclitaxel—kidney cancer	0.000246	0.00129	CcSEcCtD
Perphenazine—Hypersensitivity—Sunitinib—kidney cancer	0.000245	0.00129	CcSEcCtD
Perphenazine—Decreased appetite—Vincristine—kidney cancer	0.000245	0.00129	CcSEcCtD
Perphenazine—Pruritus—Sorafenib—kidney cancer	0.000245	0.00129	CcSEcCtD
Perphenazine—Insomnia—Gemcitabine—kidney cancer	0.000242	0.00127	CcSEcCtD
Perphenazine—Headache—Erlotinib—kidney cancer	0.000241	0.00127	CcSEcCtD
Perphenazine—Loss of consciousness—Paclitaxel—kidney cancer	0.000241	0.00127	CcSEcCtD
Perphenazine—Pain—Vincristine—kidney cancer	0.000241	0.00127	CcSEcCtD
Perphenazine—Constipation—Vincristine—kidney cancer	0.000241	0.00127	CcSEcCtD
Perphenazine—Cough—Paclitaxel—kidney cancer	0.000239	0.00126	CcSEcCtD
Perphenazine—Dyspnoea—Gemcitabine—kidney cancer	0.000238	0.00126	CcSEcCtD
Perphenazine—Somnolence—Gemcitabine—kidney cancer	0.000238	0.00125	CcSEcCtD
Perphenazine—Convulsion—Paclitaxel—kidney cancer	0.000238	0.00125	CcSEcCtD
Perphenazine—Diarrhoea—Sorafenib—kidney cancer	0.000237	0.00125	CcSEcCtD
Perphenazine—Hypertension—Paclitaxel—kidney cancer	0.000237	0.00125	CcSEcCtD
Perphenazine—Pruritus—Sunitinib—kidney cancer	0.000236	0.00124	CcSEcCtD
Perphenazine—Decreased appetite—Gemcitabine—kidney cancer	0.000232	0.00122	CcSEcCtD
Perphenazine—Hypersensitivity—Dactinomycin—kidney cancer	0.000232	0.00122	CcSEcCtD
Perphenazine—Cardiac arrest—Doxorubicin—kidney cancer	0.000229	0.00121	CcSEcCtD
Perphenazine—Dizziness—Sorafenib—kidney cancer	0.000229	0.00121	CcSEcCtD
Perphenazine—Constipation—Gemcitabine—kidney cancer	0.000229	0.0012	CcSEcCtD
Perphenazine—Pain—Gemcitabine—kidney cancer	0.000229	0.0012	CcSEcCtD
Perphenazine—Dry mouth—Paclitaxel—kidney cancer	0.000228	0.0012	CcSEcCtD
Perphenazine—Diarrhoea—Sunitinib—kidney cancer	0.000228	0.0012	CcSEcCtD
Perphenazine—Ataxia—Doxorubicin—kidney cancer	0.000227	0.00119	CcSEcCtD
Perphenazine—Confusional state—Paclitaxel—kidney cancer	0.000226	0.00119	CcSEcCtD
Perphenazine—Erythema—Capecitabine—kidney cancer	0.000225	0.00119	CcSEcCtD
Perphenazine—Anaphylactic shock—Paclitaxel—kidney cancer	0.000224	0.00118	CcSEcCtD
Perphenazine—Body temperature increased—Vincristine—kidney cancer	0.000223	0.00117	CcSEcCtD
Perphenazine—Infection—Paclitaxel—kidney cancer	0.000222	0.00117	CcSEcCtD
Perphenazine—Dizziness—Sunitinib—kidney cancer	0.00022	0.00116	CcSEcCtD
Perphenazine—Shock—Paclitaxel—kidney cancer	0.00022	0.00116	CcSEcCtD
Perphenazine—Orthostatic hypotension—Doxorubicin—kidney cancer	0.00022	0.00116	CcSEcCtD
Perphenazine—Tachycardia—Paclitaxel—kidney cancer	0.000218	0.00115	CcSEcCtD
Perphenazine—Headache—Sorafenib—kidney cancer	0.000217	0.00114	CcSEcCtD
Perphenazine—Muscle spasms—Capecitabine—kidney cancer	0.000216	0.00114	CcSEcCtD
Perphenazine—Diarrhoea—Dactinomycin—kidney cancer	0.000216	0.00114	CcSEcCtD
Perphenazine—Anorexia—Paclitaxel—kidney cancer	0.000213	0.00112	CcSEcCtD
Perphenazine—Muscular weakness—Doxorubicin—kidney cancer	0.000212	0.00112	CcSEcCtD
Perphenazine—Vision blurred—Capecitabine—kidney cancer	0.000212	0.00112	CcSEcCtD
Perphenazine—Body temperature increased—Gemcitabine—kidney cancer	0.000211	0.00111	CcSEcCtD
Perphenazine—Hypotension—Paclitaxel—kidney cancer	0.000209	0.0011	CcSEcCtD
Perphenazine—Headache—Sunitinib—kidney cancer	0.000209	0.0011	CcSEcCtD
Perphenazine—Asthma—Doxorubicin—kidney cancer	0.000208	0.0011	CcSEcCtD
Perphenazine—Dysphagia—Doxorubicin—kidney cancer	0.000208	0.0011	CcSEcCtD
Perphenazine—Hypersensitivity—Vincristine—kidney cancer	0.000208	0.00109	CcSEcCtD
Perphenazine—Eosinophilia—Doxorubicin—kidney cancer	0.000206	0.00109	CcSEcCtD
Perphenazine—Insomnia—Paclitaxel—kidney cancer	0.000202	0.00107	CcSEcCtD
Perphenazine—Syncope—Capecitabine—kidney cancer	0.000202	0.00106	CcSEcCtD
Perphenazine—Leukopenia—Capecitabine—kidney cancer	0.000201	0.00106	CcSEcCtD
Perphenazine—Dyspnoea—Paclitaxel—kidney cancer	0.0002	0.00105	CcSEcCtD
Perphenazine—Somnolence—Paclitaxel—kidney cancer	0.000199	0.00105	CcSEcCtD
Perphenazine—Loss of consciousness—Capecitabine—kidney cancer	0.000198	0.00104	CcSEcCtD
Perphenazine—Pancytopenia—Doxorubicin—kidney cancer	0.000198	0.00104	CcSEcCtD
Perphenazine—Cough—Capecitabine—kidney cancer	0.000196	0.00103	CcSEcCtD
Perphenazine—Decreased appetite—Paclitaxel—kidney cancer	0.000195	0.00103	CcSEcCtD
Perphenazine—Hypertension—Capecitabine—kidney cancer	0.000194	0.00102	CcSEcCtD
Perphenazine—Diarrhoea—Vincristine—kidney cancer	0.000193	0.00102	CcSEcCtD
Perphenazine—Pain—Paclitaxel—kidney cancer	0.000191	0.00101	CcSEcCtD
Perphenazine—Constipation—Paclitaxel—kidney cancer	0.000191	0.00101	CcSEcCtD
Perphenazine—Photosensitivity reaction—Doxorubicin—kidney cancer	0.00019	0.001	CcSEcCtD
Perphenazine—Pruritus—Gemcitabine—kidney cancer	0.000189	0.000996	CcSEcCtD
Perphenazine—Hyperglycaemia—Doxorubicin—kidney cancer	0.000188	0.00099	CcSEcCtD
Perphenazine—Dry mouth—Capecitabine—kidney cancer	0.000187	0.000987	CcSEcCtD
Perphenazine—Dizziness—Vincristine—kidney cancer	0.000186	0.000982	CcSEcCtD
Perphenazine—Drowsiness—Doxorubicin—kidney cancer	0.000186	0.000978	CcSEcCtD
Perphenazine—Confusional state—Capecitabine—kidney cancer	0.000185	0.000976	CcSEcCtD
Perphenazine—Diarrhoea—Gemcitabine—kidney cancer	0.000183	0.000964	CcSEcCtD
Perphenazine—Infection—Capecitabine—kidney cancer	0.000182	0.000961	CcSEcCtD
Perphenazine—Jaundice—Doxorubicin—kidney cancer	0.000181	0.000953	CcSEcCtD
Perphenazine—Shock—Capecitabine—kidney cancer	0.000181	0.000952	CcSEcCtD
Perphenazine—Tachycardia—Capecitabine—kidney cancer	0.000179	0.000944	CcSEcCtD
Perphenazine—Urticaria—Paclitaxel—kidney cancer	0.000178	0.000937	CcSEcCtD
Perphenazine—Body temperature increased—Paclitaxel—kidney cancer	0.000177	0.000932	CcSEcCtD
Perphenazine—Headache—Vincristine—kidney cancer	0.000177	0.00093	CcSEcCtD
Perphenazine—Anorexia—Capecitabine—kidney cancer	0.000175	0.000922	CcSEcCtD
Perphenazine—Agranulocytosis—Doxorubicin—kidney cancer	0.000173	0.000913	CcSEcCtD
Perphenazine—Hypotension—Capecitabine—kidney cancer	0.000172	0.000904	CcSEcCtD
Perphenazine—Domperidone—ABCB1—kidney cancer	0.00017	0.0588	CrCbGaD
Perphenazine—Bradycardia—Doxorubicin—kidney cancer	0.00017	0.000894	CcSEcCtD
Perphenazine—Chlorpromazine—BCHE—kidney cancer	0.000169	0.0586	CrCbGaD
Perphenazine—Headache—Gemcitabine—kidney cancer	0.000167	0.000882	CcSEcCtD
Perphenazine—Insomnia—Capecitabine—kidney cancer	0.000166	0.000875	CcSEcCtD
Perphenazine—Hypoaesthesia—Doxorubicin—kidney cancer	0.000166	0.000874	CcSEcCtD
Perphenazine—Hypersensitivity—Paclitaxel—kidney cancer	0.000165	0.000869	CcSEcCtD
Perphenazine—Oedema peripheral—Doxorubicin—kidney cancer	0.000164	0.000865	CcSEcCtD
Perphenazine—Dyspnoea—Capecitabine—kidney cancer	0.000164	0.000863	CcSEcCtD
Perphenazine—Decreased appetite—Capecitabine—kidney cancer	0.00016	0.000841	CcSEcCtD
Perphenazine—Pruritus—Paclitaxel—kidney cancer	0.000158	0.000834	CcSEcCtD
Perphenazine—Constipation—Capecitabine—kidney cancer	0.000157	0.000828	CcSEcCtD
Perphenazine—Pain—Capecitabine—kidney cancer	0.000157	0.000828	CcSEcCtD
Perphenazine—Diarrhoea—Paclitaxel—kidney cancer	0.000153	0.000807	CcSEcCtD
Perphenazine—Dizziness—Paclitaxel—kidney cancer	0.000148	0.00078	CcSEcCtD
Perphenazine—Urticaria—Capecitabine—kidney cancer	0.000146	0.000769	CcSEcCtD
Perphenazine—Body temperature increased—Capecitabine—kidney cancer	0.000145	0.000765	CcSEcCtD
Perphenazine—Erythema—Doxorubicin—kidney cancer	0.000145	0.000764	CcSEcCtD
Perphenazine—Nefazodone—ABCB1—kidney cancer	0.000141	0.0489	CrCbGaD
Perphenazine—Headache—Paclitaxel—kidney cancer	0.00014	0.000739	CcSEcCtD
Perphenazine—Muscle spasms—Doxorubicin—kidney cancer	0.000139	0.000735	CcSEcCtD
Perphenazine—Triflupromazine—ABCB1—kidney cancer	0.000138	0.0476	CrCbGaD
Perphenazine—Vision blurred—Doxorubicin—kidney cancer	0.000137	0.00072	CcSEcCtD
Perphenazine—Hypersensitivity—Capecitabine—kidney cancer	0.000135	0.000713	CcSEcCtD
Perphenazine—Agitation—Doxorubicin—kidney cancer	0.000133	0.000702	CcSEcCtD
Perphenazine—Aripiprazole—ABCB1—kidney cancer	0.000131	0.0454	CrCbGaD
Perphenazine—Trazodone—ABCB1—kidney cancer	0.000131	0.0452	CrCbGaD
Perphenazine—Syncope—Doxorubicin—kidney cancer	0.00013	0.000685	CcSEcCtD
Perphenazine—Pruritus—Capecitabine—kidney cancer	0.00013	0.000685	CcSEcCtD
Perphenazine—Leukopenia—Doxorubicin—kidney cancer	0.00013	0.000684	CcSEcCtD
Perphenazine—Loss of consciousness—Doxorubicin—kidney cancer	0.000128	0.000672	CcSEcCtD
Perphenazine—Cough—Doxorubicin—kidney cancer	0.000127	0.000667	CcSEcCtD
Perphenazine—Convulsion—Doxorubicin—kidney cancer	0.000126	0.000662	CcSEcCtD
Perphenazine—Diarrhoea—Capecitabine—kidney cancer	0.000126	0.000662	CcSEcCtD
Perphenazine—Hypertension—Doxorubicin—kidney cancer	0.000125	0.00066	CcSEcCtD
Perphenazine—Dizziness—Capecitabine—kidney cancer	0.000121	0.00064	CcSEcCtD
Perphenazine—Dry mouth—Doxorubicin—kidney cancer	0.000121	0.000636	CcSEcCtD
Perphenazine—Confusional state—Doxorubicin—kidney cancer	0.000119	0.000629	CcSEcCtD
Perphenazine—Anaphylactic shock—Doxorubicin—kidney cancer	0.000118	0.000624	CcSEcCtD
Perphenazine—Infection—Doxorubicin—kidney cancer	0.000118	0.00062	CcSEcCtD
Perphenazine—Shock—Doxorubicin—kidney cancer	0.000116	0.000614	CcSEcCtD
Perphenazine—Tachycardia—Doxorubicin—kidney cancer	0.000116	0.000609	CcSEcCtD
Perphenazine—Headache—Capecitabine—kidney cancer	0.000115	0.000606	CcSEcCtD
Perphenazine—Anorexia—Doxorubicin—kidney cancer	0.000113	0.000595	CcSEcCtD
Perphenazine—Hypotension—Doxorubicin—kidney cancer	0.000111	0.000583	CcSEcCtD
Perphenazine—Insomnia—Doxorubicin—kidney cancer	0.000107	0.000564	CcSEcCtD
Perphenazine—Fluphenazine—ABCB1—kidney cancer	0.000106	0.0366	CrCbGaD
Perphenazine—Dyspnoea—Doxorubicin—kidney cancer	0.000106	0.000556	CcSEcCtD
Perphenazine—Somnolence—Doxorubicin—kidney cancer	0.000105	0.000555	CcSEcCtD
Perphenazine—Decreased appetite—Doxorubicin—kidney cancer	0.000103	0.000542	CcSEcCtD
Perphenazine—Pain—Doxorubicin—kidney cancer	0.000101	0.000533	CcSEcCtD
Perphenazine—Constipation—Doxorubicin—kidney cancer	0.000101	0.000533	CcSEcCtD
Perphenazine—Clomipramine—ABCB1—kidney cancer	9.68e-05	0.0335	CrCbGaD
Perphenazine—Chlorprothixene—ABCB1—kidney cancer	9.63e-05	0.0333	CrCbGaD
Perphenazine—Urticaria—Doxorubicin—kidney cancer	9.41e-05	0.000496	CcSEcCtD
Perphenazine—Body temperature increased—Doxorubicin—kidney cancer	9.36e-05	0.000493	CcSEcCtD
Perphenazine—Hypersensitivity—Doxorubicin—kidney cancer	8.72e-05	0.00046	CcSEcCtD
Perphenazine—Promethazine—ABCB1—kidney cancer	8.57e-05	0.0297	CrCbGaD
Perphenazine—Trifluoperazine—ABCB1—kidney cancer	8.46e-05	0.0293	CrCbGaD
Perphenazine—Pruritus—Doxorubicin—kidney cancer	8.38e-05	0.000441	CcSEcCtD
Perphenazine—Quetiapine—ABCB1—kidney cancer	8.2e-05	0.0284	CrCbGaD
Perphenazine—Diarrhoea—Doxorubicin—kidney cancer	8.1e-05	0.000427	CcSEcCtD
Perphenazine—Dizziness—Doxorubicin—kidney cancer	7.83e-05	0.000413	CcSEcCtD
Perphenazine—Headache—Doxorubicin—kidney cancer	7.42e-05	0.000391	CcSEcCtD
Perphenazine—Chlorpromazine—ABCB1—kidney cancer	6.64e-05	0.023	CrCbGaD
Perphenazine—CALM3—Signaling by GPCR—MAPK3—kidney cancer	5.09e-06	3.02e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—KRAS—kidney cancer	5.09e-06	3.01e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—RELA—kidney cancer	5.09e-06	3.01e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—CCND1—kidney cancer	5.09e-06	3.01e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—JUN—kidney cancer	5.08e-06	3.01e-05	CbGpPWpGaD
Perphenazine—ADRA2A—GPCR downstream signaling—PIK3CA—kidney cancer	5.08e-06	3.01e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—PIK3CA—kidney cancer	5.07e-06	3e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—POMC—kidney cancer	5.06e-06	3e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—CCND1—kidney cancer	5.06e-06	3e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—ERBB2—kidney cancer	5.06e-06	2.99e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—PIK3CA—kidney cancer	5.06e-06	2.99e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—JUN—kidney cancer	5.05e-06	2.99e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—CTNNB1—kidney cancer	5.04e-06	2.98e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—PTEN—kidney cancer	5.03e-06	2.98e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—RAF1—kidney cancer	5.03e-06	2.98e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—RAF1—kidney cancer	5.02e-06	2.97e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—KRAS—kidney cancer	5.02e-06	2.97e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—CTNNB1—kidney cancer	5.01e-06	2.97e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—RELA—kidney cancer	5.01e-06	2.97e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—BRAF—kidney cancer	5e-06	2.96e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—RELA—kidney cancer	5e-06	2.96e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—CTNNB1—kidney cancer	4.99e-06	2.96e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—CTNNB1—kidney cancer	4.99e-06	2.96e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MTOR—kidney cancer	4.99e-06	2.96e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—ERBB2—kidney cancer	4.98e-06	2.95e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—ERBB2—kidney cancer	4.96e-06	2.94e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—PTGS2—kidney cancer	4.96e-06	2.94e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—MAPK3—kidney cancer	4.93e-06	2.92e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—MAPK3—kidney cancer	4.93e-06	2.92e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—CYP1A1—kidney cancer	4.91e-06	2.91e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—PTEN—kidney cancer	4.91e-06	2.91e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MTOR—kidney cancer	4.91e-06	2.91e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MTOR—kidney cancer	4.9e-06	2.9e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—POMC—kidney cancer	4.9e-06	2.9e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—POMC—kidney cancer	4.9e-06	2.9e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—PTEN—kidney cancer	4.89e-06	2.89e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—MAPK3—kidney cancer	4.88e-06	2.89e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—PTEN—kidney cancer	4.87e-06	2.88e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—PTEN—kidney cancer	4.87e-06	2.88e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—MAPK1—kidney cancer	4.85e-06	2.87e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—BRAF—kidney cancer	4.84e-06	2.86e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—BRAF—kidney cancer	4.84e-06	2.86e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—PTGS2—kidney cancer	4.83e-06	2.86e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—MYC—kidney cancer	4.75e-06	2.81e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.72e-06	2.8e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—POMC—kidney cancer	4.7e-06	2.78e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—MAPK1—kidney cancer	4.69e-06	2.78e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—MAPK1—kidney cancer	4.69e-06	2.78e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CDKN1B—kidney cancer	4.68e-06	2.77e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—PIK3CA—kidney cancer	4.68e-06	2.77e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—PIK3CA—kidney cancer	4.68e-06	2.77e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—PTGS2—kidney cancer	4.67e-06	2.77e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—PTGS2—kidney cancer	4.67e-06	2.77e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—MAPK3—kidney cancer	4.65e-06	2.76e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—MAPK1—kidney cancer	4.64e-06	2.75e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—PTEN—kidney cancer	4.62e-06	2.73e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—PIK3CA—kidney cancer	4.61e-06	2.73e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CDKN1B—kidney cancer	4.61e-06	2.73e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CDKN1B—kidney cancer	4.6e-06	2.72e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—IL2—kidney cancer	4.58e-06	2.71e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—KRAS—kidney cancer	4.58e-06	2.71e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—RAF1—kidney cancer	4.58e-06	2.71e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—RELA—kidney cancer	4.56e-06	2.7e-05	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—TP53—kidney cancer	4.53e-06	2.68e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—ERBB2—kidney cancer	4.53e-06	2.68e-05	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—TP53—kidney cancer	4.52e-06	2.68e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—IL2—kidney cancer	4.51e-06	2.67e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—MAPK3—kidney cancer	4.5e-06	2.67e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—MAPK3—kidney cancer	4.5e-06	2.67e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—IL2—kidney cancer	4.5e-06	2.66e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CCND1—kidney cancer	4.47e-06	2.65e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MTOR—kidney cancer	4.47e-06	2.65e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—JUN—kidney cancer	4.46e-06	2.64e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—VEGFA—kidney cancer	4.44e-06	2.63e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—MAPK1—kidney cancer	4.43e-06	2.62e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—KRAS—kidney cancer	4.43e-06	2.62e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—KRAS—kidney cancer	4.43e-06	2.62e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CTNNB1—kidney cancer	4.42e-06	2.62e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—VEGFA—kidney cancer	4.41e-06	2.61e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CCND1—kidney cancer	4.4e-06	2.6e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—JUN—kidney cancer	4.39e-06	2.6e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CCND1—kidney cancer	4.39e-06	2.6e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—KRAS—kidney cancer	4.39e-06	2.6e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—JUN—kidney cancer	4.38e-06	2.59e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CTNNB1—kidney cancer	4.35e-06	2.58e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—GSTP1—kidney cancer	4.35e-06	2.58e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CTNNB1—kidney cancer	4.34e-06	2.57e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—PTEN—kidney cancer	4.33e-06	2.56e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—POMC—kidney cancer	4.32e-06	2.56e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—PTEN—kidney cancer	4.31e-06	2.55e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—MAPK3—kidney cancer	4.3e-06	2.55e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—POMC—kidney cancer	4.29e-06	2.54e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—MAPK1—kidney cancer	4.28e-06	2.54e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—MAPK1—kidney cancer	4.28e-06	2.54e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—PTEN—kidney cancer	4.24e-06	2.51e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—PTEN—kidney cancer	4.23e-06	2.51e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—PTEN—kidney cancer	4.21e-06	2.49e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—PIK3CA—kidney cancer	4.21e-06	2.49e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PTGS2—kidney cancer	4.2e-06	2.49e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—MAPK3—kidney cancer	4.2e-06	2.49e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CDKN1B—kidney cancer	4.19e-06	2.48e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—KRAS—kidney cancer	4.18e-06	2.48e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—MYC—kidney cancer	4.18e-06	2.48e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—MAPK3—kidney cancer	4.17e-06	2.47e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—RAF1—kidney cancer	4.17e-06	2.47e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—MAPK3—kidney cancer	4.16e-06	2.46e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—MAPK3—kidney cancer	4.16e-06	2.46e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—RELA—kidney cancer	4.16e-06	2.46e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—ERBB2—kidney cancer	4.13e-06	2.45e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—ABCB1—kidney cancer	4.12e-06	2.44e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—IL2—kidney cancer	4.1e-06	2.43e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—MAPK1—kidney cancer	4.09e-06	2.42e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—MYC—kidney cancer	4.08e-06	2.42e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MTOR—kidney cancer	4.08e-06	2.41e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—PTEN—kidney cancer	4.07e-06	2.41e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—PTEN—kidney cancer	4.07e-06	2.41e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—PIK3CA—kidney cancer	4.07e-06	2.41e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—PIK3CA—kidney cancer	4.07e-06	2.41e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—MYC—kidney cancer	4.06e-06	2.4e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—KRAS—kidney cancer	4.05e-06	2.4e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—KRAS—kidney cancer	4.05e-06	2.4e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—MYC—kidney cancer	4.04e-06	2.39e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—MYC—kidney cancer	4.04e-06	2.39e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—RAF1—kidney cancer	4.04e-06	2.39e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—RAF1—kidney cancer	4.04e-06	2.39e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.04e-06	2.39e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—PIK3CA—kidney cancer	4.03e-06	2.39e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—RELA—kidney cancer	4.02e-06	2.38e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—RELA—kidney cancer	4.02e-06	2.38e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—GSTM1—kidney cancer	4e-06	2.37e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CCND1—kidney cancer	4e-06	2.37e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—ERBB2—kidney cancer	4e-06	2.37e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—ERBB2—kidney cancer	4e-06	2.37e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—MAPK1—kidney cancer	3.99e-06	2.36e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—JUN—kidney cancer	3.99e-06	2.36e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—MAPK1—kidney cancer	3.97e-06	2.35e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CTNNB1—kidney cancer	3.96e-06	2.35e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—MAPK1—kidney cancer	3.96e-06	2.34e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—MAPK1—kidney cancer	3.96e-06	2.34e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MTOR—kidney cancer	3.94e-06	2.34e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MTOR—kidney cancer	3.94e-06	2.34e-05	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—TP53—kidney cancer	3.9e-06	2.31e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—VEGFA—kidney cancer	3.89e-06	2.31e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—KRAS—kidney cancer	3.86e-06	2.29e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—PTEN—kidney cancer	3.86e-06	2.29e-05	CbGpPWpGaD
Perphenazine—CALM3—Immune System—PIK3CA—kidney cancer	3.84e-06	2.28e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—VEGFA—kidney cancer	3.83e-06	2.27e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CDKN1B—kidney cancer	3.82e-06	2.27e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—VEGFA—kidney cancer	3.82e-06	2.26e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CYP1A1—kidney cancer	3.79e-06	2.25e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—KRAS—kidney cancer	3.77e-06	2.23e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—KRAS—kidney cancer	3.75e-06	2.22e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PTGS2—kidney cancer	3.75e-06	2.22e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—IL2—kidney cancer	3.74e-06	2.22e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—KRAS—kidney cancer	3.74e-06	2.21e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—KRAS—kidney cancer	3.74e-06	2.21e-05	CbGpPWpGaD
Perphenazine—CALM2—Immune System—PIK3CA—kidney cancer	3.72e-06	2.2e-05	CbGpPWpGaD
Perphenazine—CALM1—Immune System—PIK3CA—kidney cancer	3.72e-06	2.2e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CDKN1B—kidney cancer	3.7e-06	2.19e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CDKN1B—kidney cancer	3.7e-06	2.19e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MAPK3—kidney cancer	3.68e-06	2.18e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PTEN—kidney cancer	3.66e-06	2.17e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—POMC—kidney cancer	3.66e-06	2.17e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CCND1—kidney cancer	3.65e-06	2.16e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—JUN—kidney cancer	3.64e-06	2.16e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MAPK3—kidney cancer	3.63e-06	2.15e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—IL2—kidney cancer	3.62e-06	2.14e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—IL2—kidney cancer	3.62e-06	2.14e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MAPK3—kidney cancer	3.62e-06	2.14e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CTNNB1—kidney cancer	3.61e-06	2.14e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MYC—kidney cancer	3.58e-06	2.12e-05	CbGpPWpGaD
Perphenazine—CALM3—Disease—PIK3CA—kidney cancer	3.55e-06	2.1e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CCND1—kidney cancer	3.53e-06	2.09e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CCND1—kidney cancer	3.53e-06	2.09e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MYC—kidney cancer	3.53e-06	2.09e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—JUN—kidney cancer	3.52e-06	2.09e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—JUN—kidney cancer	3.52e-06	2.09e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—PTEN—kidney cancer	3.52e-06	2.09e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MYC—kidney cancer	3.52e-06	2.08e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MAPK1—kidney cancer	3.51e-06	2.08e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CTNNB1—kidney cancer	3.5e-06	2.07e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CTNNB1—kidney cancer	3.5e-06	2.07e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—VEGFA—kidney cancer	3.49e-06	2.06e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—PIK3CA—kidney cancer	3.46e-06	2.05e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MAPK1—kidney cancer	3.45e-06	2.04e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PTGS2—kidney cancer	3.45e-06	2.04e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—PIK3CA—kidney cancer	3.45e-06	2.04e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MAPK1—kidney cancer	3.44e-06	2.04e-05	CbGpPWpGaD
Perphenazine—CALM2—Disease—PIK3CA—kidney cancer	3.43e-06	2.03e-05	CbGpPWpGaD
Perphenazine—CALM1—Disease—PIK3CA—kidney cancer	3.43e-06	2.03e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PTGS2—kidney cancer	3.42e-06	2.03e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PTEN—kidney cancer	3.41e-06	2.02e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PTEN—kidney cancer	3.41e-06	2.02e-05	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TP53—kidney cancer	3.35e-06	1.99e-05	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TP53—kidney cancer	3.33e-06	1.97e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—KRAS—kidney cancer	3.31e-06	1.96e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MAPK3—kidney cancer	3.3e-06	1.95e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PTEN—kidney cancer	3.27e-06	1.94e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—KRAS—kidney cancer	3.26e-06	1.93e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—PIK3CA—kidney cancer	3.26e-06	1.93e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—KRAS—kidney cancer	3.25e-06	1.93e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MYC—kidney cancer	3.21e-06	1.9e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—VEGFA—kidney cancer	3.18e-06	1.88e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MAPK1—kidney cancer	3.14e-06	1.86e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—VEGFA—kidney cancer	3.08e-06	1.82e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—VEGFA—kidney cancer	3.08e-06	1.82e-05	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—PIK3CA—kidney cancer	3.05e-06	1.81e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—PIK3CA—kidney cancer	3.04e-06	1.8e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MAPK3—kidney cancer	3.01e-06	1.78e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PTEN—kidney cancer	3.01e-06	1.78e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—PIK3CA—kidney cancer	2.99e-06	1.77e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—PIK3CA—kidney cancer	2.99e-06	1.77e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PTEN—kidney cancer	2.98e-06	1.77e-05	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—PIK3CA—kidney cancer	2.97e-06	1.76e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—KRAS—kidney cancer	2.96e-06	1.76e-05	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TP53—kidney cancer	2.94e-06	1.74e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MYC—kidney cancer	2.93e-06	1.73e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PTGS2—kidney cancer	2.92e-06	1.73e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MAPK3—kidney cancer	2.91e-06	1.72e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MAPK3—kidney cancer	2.91e-06	1.72e-05	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TP53—kidney cancer	2.9e-06	1.71e-05	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TP53—kidney cancer	2.89e-06	1.71e-05	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—PIK3CA—kidney cancer	2.87e-06	1.7e-05	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—PIK3CA—kidney cancer	2.87e-06	1.7e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MAPK1—kidney cancer	2.86e-06	1.7e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MYC—kidney cancer	2.83e-06	1.68e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MYC—kidney cancer	2.83e-06	1.68e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—POMC—kidney cancer	2.83e-06	1.67e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MAPK1—kidney cancer	2.77e-06	1.64e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MAPK1—kidney cancer	2.77e-06	1.64e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—PIK3CA—kidney cancer	2.72e-06	1.61e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—KRAS—kidney cancer	2.7e-06	1.6e-05	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TP53—kidney cancer	2.63e-06	1.56e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—KRAS—kidney cancer	2.62e-06	1.55e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—KRAS—kidney cancer	2.62e-06	1.55e-05	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—PIK3CA—kidney cancer	2.58e-06	1.53e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PTEN—kidney cancer	2.55e-06	1.51e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—PIK3CA—kidney cancer	2.48e-06	1.47e-05	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TP53—kidney cancer	2.4e-06	1.42e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—PIK3CA—kidney cancer	2.4e-06	1.42e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—PIK3CA—kidney cancer	2.4e-06	1.42e-05	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TP53—kidney cancer	2.33e-06	1.38e-05	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TP53—kidney cancer	2.33e-06	1.38e-05	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—PIK3CA—kidney cancer	2.31e-06	1.37e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PTGS2—kidney cancer	2.26e-06	1.34e-05	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—PIK3CA—kidney cancer	2.12e-06	1.26e-05	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—PIK3CA—kidney cancer	2.1e-06	1.25e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PTEN—kidney cancer	1.97e-06	1.16e-05	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.8e-06	1.06e-05	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.39e-06	8.22e-06	CbGpPWpGaD
